Third Amendment to Plasma Sale/Purchase AgreementPlasma Sale/Purchase Agreement • October 19th, 2007 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations
This Third Amendment to Plasma Sale/Purchase Agreement (the “Third Agreement”) is made and entered into by and between ZLB Bioplasma Inc., a Delaware corporation doing business as ZLB Plasma Services (“ZLB”), having an address at 5201 Congress Avenue Suite 220, Boca Raton, Florida 33487, and Talecris Biotherapeutics, Inc., a Delaware Corporation (“Talecris”), having an address at 8368 U.S. Highway 70W, Clayton, North Carolina 27520. This Third Amendment is made effective as of January 1, 2006 (the “Effective Date”).
PLASMA SALE/PURCHASE AGREEMENTPlasma Sale/Purchase Agreement • July 21st, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • Delaware
This Plasma Sale/Purchase Agreement and its Schedules (the “Agreement”) is entered into as of August 12, 2008 by and between ZLB Bioplasma Inc., a Delaware corporation doing business as ZLB Plasma, having an address at 5201 Congress Avenue, Suite 220, Boca Raton, Florida 33487 (“ZLB”), and Talecris Biotherapeutics, Inc., a Delaware corporation, having an address at 8368 U.S. Highway 70W, Clayton, NC 27520 (“Talecris”). ZLB and Talecris are at times referred to in this Agreement individually as a “Party” and/or collectively as the “Parties.”
Second Amendment to Plasma Sale/Purchase AgreementPlasma Sale/Purchase Agreement • October 19th, 2007 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations
This Second Amendment to Plasma/Sale Purchase Agreement (the “Second Amendment”) is made and entered into, effective as of October 13, 2005 (the “Effective Date”), by and between ZLB Bioplasma Inc., doing business as ZLB Plasma Services (“ZLB”) and Talecris Biotherapeutics, Inc., a Delaware Corporation, having an address at 8368 U.S. Highway 70W, Clayton, North Carolina 27520 (“Talecris”), successor in interest to Bayer Healthcare L.L.C.
PLASMA SALE/PURCHASE AGREEMENTPlasma Sale/Purchase Agreement • October 19th, 2007 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • New York
This Plasma Sale/Purchase Agreement (the “Agreement) is made, entered into and effective as of January 1, 2003 (the “Effective Date”) by and between ZLB Bioplasma Inc., a Delaware corporation doing business as ZLB Plasma Services, having an address at 5201 Congress Avenue, Suite D220, Boca Raton, Florida 33487 (“ZLB”), and Bayer HealthCare LLC, a Delaware limited liability company, having an address at 79 T.W. Alexander Dr., 4101 Research Commons, Research Triangle Park, North Carolina 27709 (“Buyer”). ZLB and Buyer are at times referred to in this Agreement individually as a “Party” and/or collectively as the “Parties.”
AMENDED AND RESTATED PLASMA SALE/PURCHASE AGREEMENTPlasma Sale/Purchase Agreement • August 19th, 2009 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations • North Carolina
This Amended and Restated Plasma Sale/Purchase Agreement (the “Agreement”) is made, entered into and effective as of the 13th day of October, 2006 (the “Effective Date”) by and between Interstate Blood Bank, Inc. doing business as IBBI having an address at 5700 Pleasant View Road, Memphis, TN 38134 (“Supplier”) and Talecris Biotherapeutics, Inc., having an address at 79 T.W. Alexander Drive, 4101 Research Commons, Research Triangle Park, North Carolina 27709 (“Talecris”). Supplier and Talecris are at times referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
AMENDMENT TO PLASMA SALE /PURCHASE AGREEMENT ZLB Bioplasma Inc. dba ZLB Plasma Services and Bayer Healthcare LLCPlasma Sale / Purchase Agreement • October 19th, 2007 • Talecris Biotherapeutics Holdings Corp. • Pharmaceutical preparations
This Amendment (“Amendment”), which shall be effective upon execution by all parties, is agreed and entered into by and between ZLB Bioplasma, Inc., a Delaware corporation doing business as ZLB Plasma Services (“ZLB”), and Bayer Healthcare LLC (“Bayer”), with respect to their certain Plasma Sale / Purchase Agreement dated as of January 1, 2003 (the “Agreement”).
